This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Cellmid Limited, Medical Therapies Limited. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Shuhei Torii: Innovator in Medical Adhesion Prevention
Introduction
Shuhei Torii is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of medical technology, particularly in the prevention of post-surgical adhesions. With a total of 2 patents, his work has the potential to improve patient outcomes following abdominal surgeries.
Latest Patents
Torii's latest patents focus on innovative solutions to prevent adhesions that can occur after abdominal surgery. The first patent, titled "Preventive for adhesion following abdominal surgery," describes the discovery that oligonucleotides which suppress midkine expression, along with antibodies that inhibit midkine activity, can effectively prevent post-surgical intraperitoneal adhesions. The second patent, "Anti-midkine antibody for preventing post-laparotomy adhesions," reiterates this discovery, emphasizing the importance of midkine suppression in reducing the risk of adhesions after surgical procedures.
Career Highlights
Throughout his career, Shuhei Torii has worked with various organizations that focus on medical advancements. Notably, he has been associated with Medical Therapies Limited and Cellmid Limited, where he has contributed to research and development in the medical field.
Collaborations
Torii has collaborated with esteemed colleagues, including Takashi Muramatsu and Kazuhiko Inoh. Their combined expertise has likely enhanced the quality and impact of his research.
Conclusion
Shuhei Torii's innovative work in preventing post-surgical adhesions showcases his dedication to improving medical practices. His patents reflect a significant advancement in surgical recovery, potentially benefiting countless patients in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile